Bristol-Myers Squibb is a global biopharmaceutical company that discovers, develops, and commercializes medicines across oncology, hematology, immunology, cardiovascular, and neuroscience areas. The company's portfolio includes treatments such as Opdivo for cancer, Eliquis for stroke prevention and blood clots, Revlimid for multiple myeloma, Orencia for rheumatoid arthritis, and various other therapies for conditions including melanoma, leukemia, psoriasis, and schizophrenia. The company distributes its products through wholesalers, pharmacies, hospitals, and government agencies.

entry readiness 23 · NOT READY · exit proximity 0

Value area 53.16–62.64 · 29% of 120d volume overhead · moderate overhead